{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-070193","form_type":"8-K","ticker":"ATNM","cik":"0001388320","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2026-06-18T21:00:24+00:00","discovered_at":"2026-06-18T21:02:00.312010+00:00","generated_at":"2026-06-18T21:04:26.755023+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Actinium submits NYSE American compliance plan after equity deficiency notice","bullets":["Received NYSE American deficiency notice on May 27, 2026, for Section 1003(a)(ii): equity below required $4M.","Submitted compliance plan on June 18, 2026, outlining intended actions to restore listing standards.","No specific plan details disclosed; exchange will review plan during continued trading.","Company faces potential delisting if plan not accepted or compliance not achieved within extension period."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-070193","json":"https://secwatch.observer/filing/0001213900-26-070193.json","markdown":"https://secwatch.observer/filing/0001213900-26-070193.md","text":"https://secwatch.observer/filing/0001213900-26-070193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026070193/0001213900-26-070193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026070193/ea0295259-8k_actinium.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T21:04:26.755023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}